CRS 2021 Poster: Using formulation design spaces and clinical data to optimize development of modified release (MR) dosage forms
Overview
Download our CRS 2021 Poster on 'Using formulation design & clinical data to optimize the development of modified release (MR) dosage forms' here.
The purpose of this study is to review the benefits of integrating product manufacturing and clinical testing to enable human PK data to inform MR composition selection in real-time, generating knowledge for future MR development (Figure 1). This platform permits the inclusion of formulation design spaces in regulatory submissions, from within which discrete compositions can be selected during the study conducted in real time.